Literature DB >> 6255532

Ketoconazole in experimental candidosis.

D Thienpont, J Van Cutsem, M Borgers.   

Abstract

A relatively large number of animal models of candidosis exist in which the efficacy of antifungal substances can be evaluated. These include models of candidosis of the skin, gastrointestinal tract, genital system, and internal organs in a variety of animal species. The efficacy of ketoconazole administered orally and topically was evaluated; when given orally in relatively low doses, ketoconazole was found to be efficacious in all of the experimental models used. Scanning and transmission electron micrographs of infected tissue demonstrated the rapidity with which Candida albicans was eradicated from the host after administration of ketoconazole.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6255532     DOI: 10.1093/clinids/2.4.570

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  6 in total

1.  Development of an orogastrointestinal mucosal model of candidiasis with dissemination to visceral organs.

Authors:  Karl V Clemons; Gloria M Gonzalez; Gaurav Singh; Jackie Imai; Marife Espiritu; Rachana Parmar; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

Review 2.  Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections.

Authors:  R C Heel; R N Brogden; A Carmine; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

3.  Distribution of oral ketoconazole to vaginal tissue.

Authors:  J J Heykants; R J Woestenborghs; M P Bisschop; J M Merkus
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

4.  The effect of ketoconazole on experimental paracoccidioidomycosis in the Syrian hamster: immunological and histopathological study.

Authors:  N G Mota; R M Viero; M T Rezkallah-Iwasso; M T Peraçoli; A M Soares; M R Montenegro
Journal:  Mycopathologia       Date:  1984-12-30       Impact factor: 2.574

5.  Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes.

Authors:  K Richardson; K W Brammer; M S Marriott; P F Troke
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

6.  Comparison of ketoconazole, Bay N7133, and Bay L9139 in the treatment of experimental vaginal candidiasis.

Authors:  J D Sobel; G Muller
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.